Ms. Anindita Bhoumik is Senior Director of Cell Therapy Research and Development at Kenai Therapeutics. To this role, she brings over 17 years of experience in extensive discovery research and driving cell therapy drug candidates into the clinic. Prior to joining Kenai Therapeutics, Ms. Bhoumik served as the Director of Research at ViaCyte, a regenerative medicine company developing novel cell replacement therapies in a retrievable cell delivery device for Type I diabetes. In addition, she has seven years of experience in melanoma cancer research pioneering new treatment strategies using gene therapy and small molecules. She has published over 25 peer-reviewed scientific publications, review articles, book chapters and U.S. patents.

Ms. Bhoumik holds a Master of Science in organic chemistry from Banaras Hindu University.